# EDGAR Filing Document

**Accession Number:** 0002041531
**File Stem:** 0001829126-25-004279
**Filing Date:** 2025-6
**Character Count:** 4309
**Document Hash:** 22aaf701ac141502a23a5ab17ef72ec4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001829126-25-004279.hdr.sgml**: 20250606

**ACCESSION NUMBER**: 0001829126-25-004279

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20250605

**ITEM INFORMATION**: Other Events

**FILED AS OF DATE**: 20250606

**DATE AS OF CHANGE**: 20250605

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bodhi Tree Biotechnology Inc
- **CENTRAL INDEX KEY:** 0002041531
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 934908449
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-284678
- **FILM NUMBER:** 251028733

**BUSINESS ADDRESS:**
- **STREET 1:** 4125 BLACKHAWK PLAZA CIRCLE, SUITE 172
- **CITY:** DANVILLE
- **STATE:** CA
- **ZIP:** 94506
- **BUSINESS PHONE:** (925)406-4528

**MAIL ADDRESS:**
- **STREET 1:** 4125 BLACKHAWK PLAZA CIRCLE, SUITE 172
- **CITY:** DANVILLE
- **STATE:** CA
- **ZIP:** 94506

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934**

Date of Report: June 5, 2025

**BODHI TREE BIOTECHNOLOGY INC.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **021-543738** | **N/A** |
| (State or other jurisdiction<br> of incorporation) | (Commission<br> File Number) | (IRS Employer<br> Identification No.) |

---

**4125 Blackhawk Plaza Circle, Suite 172**

**<u>Danville, CA 93506</u>**

(Address of principal executive offices)

Registrant's telephone number, including area code: **<u>(925) 406-4528</u>**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Company under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbols | Name of each exchange on which registered |
| **N/A** | **N/A** | **N/A** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 8.01 Other Events**

On February 4, 2025, Bodhi Tree Technology Inc. (the "Company") filed a registration statement on Form S-1, as amended, ("Registration Statement") with the Securities and Exchange Commission ("SEC"). The Registration Statement contained an immaterial inaccuracy, disclosing that 55 accredited investors participated in a private placement transaction. The correct number of accredited investors is 29.

On April 15, 2025, the Company filed a Form D with the SEC in connection with private placement transactions it conducted. The initial filing contained a typographical error indicating that 29 non-accredited investors participated in the transactions. In fact, no non-accredited investors participated in the transactions. The Company filed an amended Form D on June 5, 2025 to correct this error.

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Bodhi Tree Biotechnology Inc.** | **Bodhi Tree Biotechnology Inc.** |
| Date: June 5, 2025 | By: | */s/ Xiaohang Wang* |
|  |  | Xiaohang Wang, Chairman and Chief Executive Officer |

---